Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.43 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27927000 | 0.93 | PDE10A (0.56) | PDE10AMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL28237594 | 0.82 | PDE10A (0.81) | PDE10AMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL27425206 | 0.81 | NPC1 (0.56) | PDE10AMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL22762116 | 0.79 | ALDH1A1 (0.45) | PDE10AMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL12066225 | 0.79 | PDE10A (1.00) | PDE10AMAPTMEN1KMT2A | |
| SCHEMBL27072915 | 0.78 | CALM1 (0.55) | ALDH1A1LMNARAB9ACALM1 | |
| SCHEMBL19287901 | 0.78 | PDE10A (0.67) | PDE10AMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL27926999 | 0.75 | PDE10A (0.68) | PDE10AMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL17179177 | 0.75 | PDE10A (0.69) | PDE10AMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL27686 | 0.75 | PDE10A (0.69) | PDE10AMAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117619591-A | Pressure-resistant high-molecular perfume spray head with double button ribs on head cap and preparation method thereof | 浙江正庄实业有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117599981-A | High-toughness polymer perfume spray head with inverted valve needle and preparation method thereof | 浙江正庄实业有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-112820893-A | Bipolar plate for electric pile, application and fuel electric pile | 坤艾新材料科技(上海)有限公司 | 2021-05-18 | — | — | CN | claimed |
| CN-222093692-U | Pressure-resistant high-polymer perfume spray head with double button ribs on head cap | 浙江正庄实业有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-221433520-U | High-toughness polymer perfume spray head with inverted valve needle | 浙江正庄实业有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-117619591-A | Pressure-resistant high-molecular perfume spray head with double button ribs on head cap and preparation method thereof | 浙江正庄实业有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-117599981-A | High-toughness polymer perfume spray head with inverted valve needle and preparation method thereof | 浙江正庄实业有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-112820893-A | Bipolar plate for electric pile, application and fuel electric pile | 坤艾新材料科技(上海)有限公司 | 2021-05-18 | — | — | CN | disclosed |
| CN-110483421-A | A kind of preparation method of quinokysalines derivative | UNIV SHENYANG NORMAL | 2019-11-22 | — | — | CN | disclosed |
| CN-108587068-B | A kind of hydrophobic fire retarding epoxide resin and preparation method thereof | 福州大学 | 2019-10-15 | — | — | CN | disclosed |
| CN-108587068-A | A kind of hydrophobic fire retarding epoxide resin and preparation method thereof | 福州大学 | 2018-09-28 | — | — | CN | disclosed |
| US-9328079-B2 | Process for producing optically active amine | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9328079-B2 | Process for producing optically active amine | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20150210657-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| US-20150210657-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| US-20150210657-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| WO-2014038666-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE | 高砂香料工業株式会社 (JP) | 2014-03-13 | — | — | WO | disclosed |
| US-7501416-B2 | Quinoxaline compounds and methods of using them | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-03-10 | — | — | US | disclosed |
| WO-2005077920-A1 | QUINOXALINE COMPOUNDS AND METHODS OF USING THEM | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-08-25 | — | — | WO | disclosed |
| US-20050176717-A1 | Quinoxaline compounds and methods of using them | BRISTOL-MYERS SQUIBB COMPANY | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176717-A1 | Quinoxaline compounds and methods of using them | NQO1, NQO2, SDHA | PDE10A 1943/4885MAPT 3545/4885MEN1 1031/4885 |
| US-20150210657-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE | HRH3, HRH1, ATIC | PDE10A 337/4885MAPT 3781/4885MEN1 1200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.